Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rossor

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
The Lancet. Neurology|August 21, 2021
The Dementia UK Ecosystem: a call to actionGiovanna Lalli, Martin Rossor, James B Rowe, et al.
BMJ (Clinical Research Ed.)|December 15, 2020
Inspired by chance: valuing patients' informal contributions to researchSebastian Crutch, Daniel Herron, James Pickett, et al.
BMC Medical Genetics|September 17, 2009
HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10qSarah E Lloyd, Martin Rossor, Nick Fox, et al.
Annals of Neurology|November 25, 2004
In vivo detection of microglial activation in frontotemporal dementiaAnnachiara Cagnin, Martin Rossor, Elizabeth L Sampson, et al.
Brain and Behavior|January 20, 2025
The Cognitive Footprint of Medication UseMarta Suárez Pinilla, Charlotte R Stoner, Martin Knapp, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
Toward common mechanisms for risk factors in Alzheimer's syndromeMiguel Medina, Zaven S Khachaturian, Martin Rossor, et al.
BMC Public Health|September 1, 2023
The link between cognitive health and neighbourhood: perceptions of the public, and of policy-makers, about problems and solutionsMadeleine Stevens, Tihana Matosevic, Marta Suarez-Pinilla, et al.
Neuroimage|October 19, 2004
Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's diseaseShona Price, Dominic Paviour, Rachael Scahill, et al.
The Lancet. Neurology|July 10, 2003
A 38-year-old man with a 9 month history of neurological and cognitive impairmentJohn Collinge, Sebastian Brandner, Angus Kennedy, et al.
Journal of Clinical Pharmacy and Therapeutics|April 28, 2020
The cognitive footprint of medication: A review of cognitive assessments in clinical trialsCharlotte R Stoner, Martin Knapp, Jeroen Luyten, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
The Lancet. Neurology|August 21, 2021
The Dementia UK Ecosystem: a call to actionGiovanna Lalli, Martin Rossor, James B Rowe, et al.
BMJ (Clinical Research Ed.)|December 15, 2020
Inspired by chance: valuing patients' informal contributions to researchSebastian Crutch, Daniel Herron, James Pickett, et al.
BMC Medical Genetics|September 17, 2009
HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10qSarah E Lloyd, Martin Rossor, Nick Fox, et al.
Annals of Neurology|November 25, 2004
In vivo detection of microglial activation in frontotemporal dementiaAnnachiara Cagnin, Martin Rossor, Elizabeth L Sampson, et al.
Brain and Behavior|January 20, 2025
The Cognitive Footprint of Medication UseMarta Suárez Pinilla, Charlotte R Stoner, Martin Knapp, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
Toward common mechanisms for risk factors in Alzheimer's syndromeMiguel Medina, Zaven S Khachaturian, Martin Rossor, et al.
BMC Public Health|September 1, 2023
The link between cognitive health and neighbourhood: perceptions of the public, and of policy-makers, about problems and solutionsMadeleine Stevens, Tihana Matosevic, Marta Suarez-Pinilla, et al.
Neuroimage|October 19, 2004
Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's diseaseShona Price, Dominic Paviour, Rachael Scahill, et al.
The Lancet. Neurology|July 10, 2003
A 38-year-old man with a 9 month history of neurological and cognitive impairmentJohn Collinge, Sebastian Brandner, Angus Kennedy, et al.
Journal of Clinical Pharmacy and Therapeutics|April 28, 2020
The cognitive footprint of medication: A review of cognitive assessments in clinical trialsCharlotte R Stoner, Martin Knapp, Jeroen Luyten, et al.
Pageof 7